Home › Funds › MONIMUS CAPITAL MANAGEMENT, LP › VKTX
MONIMUS CAPITAL MANAGEMENT, LP position in VKTX
VIKING THERAPEUTICS INC · Health Care
MONIMUS CAPITAL MANAGEMENT, LP reported holding 66,502 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.60% of its reported portfolio and ranking #48 among its reported holdings. MONIMUS CAPITAL MANAGEMENT, LP has disclosed VKTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MONIMUS CAPITAL MANAGEMENT, LP's VKTX position evolved
MONIMUS CAPITAL MANAGEMENT, LP first disclosed a stake in VKTX in Q4 2024 at 21,006 shares (US$845K). The position peaked in Q2 2026 at 66,502 shares, worth US$2.6M. Across 7 filings, MONIMUS CAPITAL MANAGEMENT, LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 66,502 shares valued at US$2.6M — a reduction of -1,339 shares quarter over quarter.. Notable position changes include a 27% increase in Q3 2025 (shares rose 34% over the following quarter), a 62% trim in Q4 2025 (shares fell 8% over the following quarter), a 493% increase in Q1 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 21.01K | $845.28K | New |
| Q1 2025 | 22.64K | $546.83K | Add |
| Q2 2025 | 23.53K | $623.60K | Add |
| Q3 2025 | 29.98K | $787.80K | Add |
| Q4 2025 | 11.44K | $402.53K | Reduce |
| Q1 2026 | 67.84K | $2.21M | Add |
| Q2 2026 | 66.50K | $2.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VKTX and 13F data
VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VKTX
- Vestal Point Capital, LP 680.00K sh · $26.53M · Q2 2026
- Eversept Partners, LP 602.92K sh · $23.52M · Q2 2026
- ADAR1 Capital Management, LLC 574.04K sh · $22.39M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 500.00K sh · $19.50M · Q2 2026
More on MONIMUS CAPITAL MANAGEMENT, LP
FAQ
How long has MONIMUS CAPITAL MANAGEMENT, LP held VKTX?
MONIMUS CAPITAL MANAGEMENT, LP has disclosed VKTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is MONIMUS CAPITAL MANAGEMENT, LP's current position in VKTX?
As of Q2 2026, MONIMUS CAPITAL MANAGEMENT, LP holds 66.50K shares of VKTX (VIKING THERAPEUTICS INC), valued at $2.59M, representing 0.60% of its reported portfolio and ranking #48.
Has MONIMUS CAPITAL MANAGEMENT, LP been buying or selling VKTX?
In the latest 13F filing (Q2 2026), MONIMUS CAPITAL MANAGEMENT, LP reduced its position in VKTX. The position peaked in Q2 2026 at 66.50K shares.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.